Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov;84(5):e13306.
doi: 10.1111/aji.13306. Epub 2020 Aug 15.

COVID-19 in pregnancy: Placental and neonatal involvement

Erica Prochaska  1   2 , Minyoung Jang  1 , Irina Burd  1
Affiliations

COVID-19 in pregnancy: Placental and neonatal involvement

Erica Prochaska et al. Am J Reprod Immunol. 2020 Nov.

Abstract

Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused over 12 million infections and more than 550 000 deaths.1 Morbidity and mortality appear partly due to host inflammatory response.2 Despite rapid, global research, the effect of SARS-CoV-2 on the developing fetus remains unclear. Case reports indicate that vertical transmission is uncommon; however, there is evidence that placental and fetal infection can occur.3-7 Placentas from infected patients show inflammatory, thrombotic, and vascular changes that have been found in other inflammatory conditions.8,9 This suggests that the inflammatory nature of SARS-CoV-2 infection during pregnancy could cause adverse obstetric and neonatal events. Exposure to intrauterine inflammation and placental changes could also potentially result in long-term, multisystemic defects in exposed infants. This review will summarize the known literature on the placenta in SARS-CoV-2 infection, evidence of vertical transmission, and possible outcomes of prenatal exposure to the virus.

Keywords: COVID-19; intrauterine infection; neonates; pathology; placenta; pregnancy.

PubMed Disclaimer

Conflict of interest statement

The authors report no potential conflicts of interest.

References

    1. COVID‐19 map . Johns Hopkins Coronavirus Resource Center Web site. https://coronavirus.jhu.edu/map.html. Accessed Jul 9, 2020
    1. Ye Q, Wang B, Mao J. The pathogenesis and treatment of the `Cytokine storm' in COVID‐19. J Infect. 2020;80(6):607‐613. 10.1016/j.jinf.2020.03.037 - DOI - PMC - PubMed
    1. Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID‐19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395(10226):809‐815. 10.1016/S0140-6736(20)30360-3 - DOI - PMC - PubMed
    1. Dong L, Tian J, He S, et al. Possible vertical transmission of SARS‐CoV‐2 from an infected mother to her newborn. JAMA. 2020;323(18):1846‐1848. 10.1001/jama.2020.4621 - DOI - PMC - PubMed
    1. Patanè L, Morotti D, Giunta MR, et al. Vertical transmission of COVID‐19: SARS‐CoV‐2 RNA on the fetal side of the placenta in pregnancies with COVID‐19 positive mothers and neonates at birth. Am J Obstetr Gynecol MFM. 2020; 10.1016/j.ajogmf.2020.100145 - DOI - PMC - PubMed